|
2023-06-28 |
2023-06-27 |
S
Sale
|
Large shareholder
|
20,871
+24.1%
451.77
US$2,937,514
|
20,871
+24.1%
|
451.77
|
US$2,937,514
|
|
|
2023-06-28 |
2023-06-26 |
S
Sale
|
Large shareholder
|
27,599
-21.7%
40.27
US$3,136,075
|
27,599
-21.7%
|
40.27
|
US$3,136,075
|
|
|
2023-06-26 |
2023-06-23 |
S
Sale
|
Large shareholder
|
43,008
+21.4%
64.79
US$1,265,829
|
43,008
+21.4%
|
64.79
|
US$1,265,829
|
|
|
2023-06-26 |
2023-06-22 |
S
Sale
|
Large shareholder
|
62,457
-1.9%
0.58
US$36,225
|
62,457
-1.9%
|
0.58
|
US$36,225
|
|
|
2023-06-22 |
2023-06-21 |
S
Sale
|
Large shareholder
|
58,183
-1.8%
0.56
US$32,582
|
58,183
-1.8%
|
0.56
|
US$32,582
|
|
|
2023-06-22 |
2023-06-20 |
S
Sale
|
Large shareholder
|
131,038
-3.8%
0.57
US$74,692
|
131,038
-3.8%
|
0.57
|
US$74,692
|
|
|
2023-06-20 |
2023-06-16 |
S
Sale
|
Large shareholder
|
46,275
-1.3%
0.58
US$26,840
|
46,275
-1.3%
|
0.58
|
US$26,840
|
|
|
2023-06-20 |
2023-06-15 |
S
Sale
|
Large shareholder
|
93,228
-2.6%
0.58
US$54,072
|
93,228
-2.6%
|
0.58
|
US$54,072
|
|
|
2023-03-16 |
2023-03-15 |
S
Sale
|
Chief Medical Officer
Officer
|
3,202
-7.3%
7.21
US$23,086
|
3,202
-7.3%
|
7.21
|
US$23,086
|
|
|
2023-03-15 |
2023-03-15 |
PrS
Proposed sale
|
Officer
Officer
|
3,202
7.11
US$22,760
|
3,202
|
7.11
|
US$22,760
|
|
|
2023-03-16 |
2023-03-14 |
S
Sale
|
Chief Medical Officer
Officer
|
3,743
-7.9%
7.66
US$28,671
|
3,743
-7.9%
|
7.66
|
US$28,671
|
|
|
2023-03-14 |
2023-03-14 |
PrS
Proposed sale
|
Officer
Officer
|
3,743
7.66
US$28,658
|
3,743
|
7.66
|
US$28,658
|
|
|
2023-03-16 |
2023-03-13 |
S
Sale
|
Chief Medical Officer
Officer
|
2,640
-5.3%
8.50
US$22,440
|
2,640
-5.3%
|
8.50
|
US$22,440
|
|
|
2023-03-13 |
2023-03-13 |
PrS
Proposed sale
|
Officer
Officer
|
2,640
8.53
US$22,519
|
2,640
|
8.53
|
US$22,519
|
|